Bioceres Corporation
| $BIOX | |
| Public | |
| Traded as | NASDAQ |
| ISIN | 🆔 |
| Industry | Biotechnology |
| Founded 📆 | 2001 |
| Founder 👔 |
|
Area served 🗺️ | |
Key people | Federico Trucco (CEO) |
| Products 📟 | HB4 Soybean HB4 Wheat |
| Members | |
Number of employees | |
| 🌐 Website | https://biocerescrops.com |
| 📇 Address | |
| 📞 telephone | |
Bioceres Group is dedicated to channeling investments into companies focused on advanced high-impact science-based solutions. It originated as Bioceres S.A, an Argentinean company of agricultural biotechnology founded in 2001, in the town of Rosario, Santa Fé. 75% of its sales are national, while the rest is exported to countries in the region, such as Brazil, Paraguay, Bolivia, Uruguay and Colombia.
One of its subsidiaries is Bioceres Crop Solutions Corp is present in the North American market and is listed on NASDAQ through its share $BIOX..[1]
History[edit]
It originated as Bioceres S.A, an Argentine company of agricultural biotechnology founded in 2001, .
The company was founded as "Bioceres S.A" in December 2001 by 23 leaders of the conservation agriculture movement in Rosario, Santa Fé Argentina, including innovative agricultural entrepreneurs, agricultural cooperatives and different actors in the agribusiness sector. Among the founders were: Roberto Peiretti, Gustavo Grobocopatel, Víctor Trucco and Rogelio Fogante who previously participated in AAPRESID. One of the groups that participated in its foundation was Los Grobo, from the Grobocopatel family.
In 2004 the company associated with Biosidus and CONICET create INDEAR (National Institute of Agrobiotechnology of Rosario), a biotechnology research and development company private partner.
In March 2019, it announced the purchase of 80% of Rizobacter Argentina SA. It also began trading on Wall Street under the name change of the company to Bioceres Crop Solutions Corp[2].
In April 2021, Bioceres voluntarily transferred its stock listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market. April 26, 2021 was the last day of trading on the New York Stock Exchange, beginning trading on the Nasdaq exchange on April 27[3].
Actually Bioceres Crop Solutions, along with its subsidiaries, provides crop productivity solutions, operates through three segments:
- Seeds and Integrated Products
- Crop Protection
- Crop Nutrition
The Seed and Integrated Products segment develops and markets seed technology, biotech events, germplasm and seed treatments. The Crop Protection segment develops, produces and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides and baits. The Crop Nutrition segment develops, produces, markets and markets inoculants, bioinductors and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa and internationally[2].
Business Units[edit]
The group is organized in 3 business units:
- Bioceres Ventures owns the group's investment management and consulting capabilities, especially focused on early-stage technologies in four main themes: biomaterials, agri-food technology, translational medicine and wellness, and carbon neutrality. The company has an investment process that allows it to participate both in the first stages of business creation (“Company building”), as well as in more advanced ones. Its strategy to address both aspects focused on the creation of two investment funds: SF500 and THEO I. SF500 is the largest Life Sciences Fund in Argentina. SF500 seeks to facilitate the creation of 500 science-technology-based startups in the next decade and promote the development of an ecosystem based on life sciences. THEO I provides an interface to co-finance Bioceres initiatives that are facing expansion and internationalization processes, while accessing the company's historical portfolio. The Bioceres Ventures portfolio is made up of several companies, including Moolec Science (the world's first industrial platform dedicated to the production of animal protein in plants for the food industry) and Héritas (a precision medicine company that merges experience in genomic diagnosis in humans with new initiatives in regenerative medicine).
- Bioceres Tech Services owns the group's R&D platforms, including high-throughput genomics, molecular biology, gene transformation and gene editing, cell and tissue culture, synthetic biology and metabolic engineering, field testing and plant breeding capabilities. Bioceres Tech Services operates through Agrality, INDEAR and INMET.
- Bioceres Crop Solutions is a fully integrated provider of crop productivity technologies designed to enable agriculture's transition to carbon neutrality. This business unit operates the HB4® and Rizobacter® brands and was listed in 2019 on the New York Stock Exchange under the ticker $BIOX. In April 2021, it began voluntarily listing on NASDAQ.
HB4 Technology[edit]
In 2003 Bioceres began a joint research collaboration with the National Council for Scientific and Technical Research (CONICET) and the Universidad Nacional del Litoral (UNL). There, the group led by Dr. Raquel Chan and Dr. Daniel González had discovered the drought tolerance effect of a sunflower gene called hahb-4. The initial discovery allowed Bioceres to develop a specific project to generate new hahb-4 transformation events on Arabidopsis thaliana. The objective of the project was to evaluate different promoters and molecular constructions to be used later on crops of agronomic interest[4]
In the course of developing the technology, a particularly efficient version of the hahb-4 gene was identified. This new, modified version of the original gene provides greater efficacy in drought conditions. The modified hahb-4 sunflower gene improves the plant's adaptation to the environment, leading to higher grain yields. However, in favorable years and high productivity, the technology does not present a performance penalty.
The wheat and soybean trials began in 2008 and 2009, respectively, and after several campaigns the most outstanding events in the field trials were selected. The final selection of the event was carried out in 2012 and 2013 for the case of wheat and soybean, respectively. Selection criteria were based on molecular data and field yields. The information generated during this stage of development was used to create an intellectual property (IP) portfolio for the technology, comprising three families of patents. In parallel, the results of the molecular and field studies were published in widely distributed scientific journals.
HB4® is currently the world's only drought-tolerant GMO technology for wheat and soybean crops[5]. The technology is being scaled up from 2020 through the "Generation HB4®" regenerative agriculture and preserved identity program.
Regulation[edit]
In 2015 HB4 soybeans received a conditional approval in Argentina[6]. In 2019 Soybean HB4 receives approval in the United States[6], Paraguay[7] and Brazil[8], 2021 in Canada[9]
In 2020, HB4 wheat received conditional approval for Brazil, Argentina's main wheat sales market. In 2021, Brazil approved HB4 wheat flour.[10] In 2022 HB4 wheat recieved approval in the United States[11], New Zealand, Australia[12], Nigeria and Colombia.
HB4 Generation[edit]
It is an agricultural production system that aims for producers to multiply wheat and soybean seeds with HB4 technology, unique in the world, offering economic benefits.
In practice, the program is implemented through an associative system, in which the company provides inputs of high technological value specially developed by Bioceres, the producers supervise the seed production service and Bioceres owns the seed and/or grain finally produced. Participation in this program is open to any producer committed to the sustainability aspects and traceability requirements established by the program.
Subsidiaries[edit]
The subsidiaries are:
- Bioceres Crop Solutions business unit that operates on NASDAQ
- INDEAR, research and development in biotechnology
- INMET, metabolic engineering solutions
- Verdeca, soy technologies (joint venture with Arcadia Biosciences)
- Trigall Genetics, development of transgenic wheat (in association with * Florimond Desprez)
- Heritas, precision medicine
- Bioceres Semillas, marketing of seeds
- AGBM, production and commercialization of chymosin
- Rizobacter Argentina S.A., crop protection
- Synertech, micro-granulated fertilizers
- Chemotechnics, crop protection
References[edit]
- ↑ "$BIOX". Bloomberg. 2022-09-23. Retrieved 2022-09-23.
- ↑ 2.0 2.1 "Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2022 Financial and Operational Results". www.businesswire.com. 2022-09-08. Retrieved 2022-09-23.
- ↑ "De Rosario a portada del Nasdaq: Bioceres Crop Solutions ya cotiza en el principal mercado electrónico de Estados Unidos | Agrofy News". news.agrofy.com.ar (in español). Retrieved 2022-09-23.
- ↑ Kelly-Linden, Jordan (2020-10-19). "Argentina to produce climate-resistant super wheat in world first". The Telegraph. ISSN 0307-1235. Retrieved 2022-09-23.
- ↑ "Analysis | We Must Learn to Love Genetically Modified Crops". Washington Post. ISSN 0190-8286. Retrieved 2022-09-23.
- ↑ 6.0 6.1 Clarín.com (2015-10-06). "Aprobaron la soja tolerante a sequía y ya podría venderse en la Argentina". Clarín (in español). Retrieved 2022-09-22.
- ↑ "Paraguay aprobó la soja HB4 tolerante a sequía | Supercampo". supercampo.perfil.com. Retrieved 2022-09-22.
- ↑ "Aprobaron en Brasil la soja HB4, tolerante a sequía | Agrofy News". news.agrofy.com.ar (in español). Retrieved 2022-09-22.
- ↑ "Canada Approves HB4 Drought Tolerant Soybeans". Crop Biotech Update. Retrieved 2022-09-22.
- ↑ "Brasil aprueba la venta de harina de trigo HB4 desde Argentina". Infocampo (in español). 2021-11-11. Retrieved 2022-09-22.
- ↑ "US FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation". Crop Biotech Update. Retrieved 2022-09-22.
- ↑ "HB4® Wheat Gets Approval in Australia and New Zealand". Crop Biotech Update. Retrieved 2022-09-22.
This article "Bioceres" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Bioceres. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
